ThomasRKlumppMD
Oncology • Philadelphia, PABreast Cancer, Hematologic Oncology
Professor of Medicine, Temple University
Dr. Klumpp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut St
Ste 320A
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 215-955-2340
Summary
- Dr. Thomas Klumpp is a hematologist-oncologist in Philadelphia, PA and is Professor of Medical Oncology with Thomas Jefferson University Hospital. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania, completed an internal medicine internship and residency at Dartmouth, a hematology-oncology fellowship and Massachusetts General Hospital, and a Bone Marrow Transplant Fellowship at Dana Farber. He has been an academic hematologist-oncologist in Philadelphia for 35 years. He specializes in hematologic malignancies, bone marrow transplantation, transfusion medicine, biostatistics, and bioinformatics.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1987 - 1990
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1982 - 1985
Perelman School of Medicine at the University of PennsylvaniaClass of 1982
Certifications & Licensure
PA State Medical License 1990 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
Clinical Trials
- Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors Start of enrollment: 1990 Nov 01
- High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer Start of enrollment: 1991 Nov 01
- Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1992 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 95 citationsImpact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaMichael Boyiadzis, Mukta Arora, John P. Klein, Anna Hassebroek, Michael T. Hemmer
Clinical Cancer Research. 2015-05-01 - 97 citationsABO blood group barrier in allogeneic bone marrow transplantation revisited.Jorg Dieter Seebach, Georg Stussi, Jakob Passweg, Fausto R. Loberiza, James Gajewski
Biology of Blood and Marrow Transplantation. 2005-12-01 - 25 citationsThe erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo diseaseStuart L. Goldberg, Pierre Noel, Thomas R. Klumpp, Gordon W. Dewald
American Journal of Clinical Oncology. 1998-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
